Medable introduced an ‘Agentic AI’ product designed to assist principal investigators in assessing electronic clinical outcome assessment data and reducing manual reconciliation. The platform provides context-aware decision support while preserving investigator accountability through human-in-the-loop controls and role-based governance. Medable positions the technology as a regulatory-ready automation layer for large trials, claiming it will lower site burden and speed clinical oversight. The rollout reflects an industry push to apply goal-oriented AI agents to regulated trial workflows while keeping explicit human sign-off for critical decisions.